BioXcel Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Down -44.6%
Portfolio Pulse from Benzinga Newsdesk
Shares of BioXcel Therapeutics have been halted on a circuit breaker to the downside, with the stock now down by 44.6%.
August 14, 2023 | 1:37 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BioXcel Therapeutics' stock has been halted on a circuit breaker, with the stock now down by 44.6%.
The news directly mentions BioXcel Therapeutics (BTAI) and reports a significant drop in its stock price. This is likely to have a negative impact on the stock in the short term as it indicates a lack of investor confidence and potential sell-off.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100